Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of recombinant Mycobacterium tuberculosis 11 kDa protein for pulmonary tuberculosis diagnosis
ChiCTR-ONC-12002012Phase 2Completed
- Sponsor
- Beijing Tuberculosis and Thoracic Tumor Research Institute
- Start
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of recombinant Mycobacterium tuberculosis ESAT6 protein in Tuberculosis (TB) and pulmonary tuberculosis (TB), sponsored by Beijing Tuberculosis and Thoracic Tumor Research Institute. Primary endpoint: Skin test reaction size. Started Jun 2008; status: completed.
02
Drugs
recombinant Mycobacterium tuberculosis ESAT6 protein
03
Conditions
Tuberculosis (TB)pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR-ONC-12002012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002012.